FDCTech posts operating profit but restatement, control weaknesses and auditor churn raise concerns

FDCTech, Inc. (PINK: FDCT) - Quick take

What's happening inside: management is growing by acquisition (AML, APL, ADS), rolling out its Condor trading technology, and recently restated Q1 2025 results after an error that materially affected Brokerage revenue and several equity line items. The company reports positive operating income for Q1 2025 but faces internal control weaknesses, multiple auditor changes, related‑party funding and an unresolved legal correspondence.

Key facts & statistics (Q1 ended March 31, 2025 vs Q1 2024)

* Total revenue: $5,976,948 (Q1 2025) vs $6,376,335 (Q1 2024) - decline of 6.26% (reported).
* Revenue by segment (Q1 2025): Brokerage $3,628,349; Wealth Management $1,534,852; Technology & Software $813,747.
* Total cost of sales: $3,117,389 (Q1 2025). Gross profit: $2,859,559 (Q1 2025) vs $2,342,101 (Q1 2024).
* Operating expenses: $2,455,306 (Q1 2025). Operating income: $404,253 (Q1 2025) vs loss $(44,246) (Q1 2024).
* Other income (expense): $(299,705) in Q1 2025 vs $877,691 in Q1 2024 - the swing drives much of the net income difference.
* Net income: $104,548 (Q1 2025) vs $833,445 (Q1 2024).
* Cash & cash equivalents: $26,996,932 (Mar 31, 2025) up from $24,781,389 (Dec 31, 2024).
* Working capital surplus: $10,082,745 (Mar 31, 2025). Accumulated deficit: $(2,480,382).
* Customer funds on the balance sheet (liability): $24,527,483 (current liabilities).
* Total assets: $45,850,386; Total liabilities: $30,195,208 (Mar 31, 2025).
* Shares outstanding: 422,584,729 (as of Aug 11, 2025).
* Notable debt / facilities: Line of credit $225,800; SBA loan (non-current) $112,057; PPP balance ~$2,389.

Restatement & accounting adjustments (management disclosure)

* The company restated Q1 2025 because APL's results were included in the wrong period. Impact (As Previously Reported → As Restated):
* Total revenue reduced by $4,135,420 (from $10,112,368 to $5,976,948).
* Brokerage (Trading) revenue reduced by $4,135,420 (from $7,763,769 to $3,628,349).
* Total cost of sales reduced by $1,811,355 (from $4,928,744 to $3,117,389).
* Gross profit reduced by $2,324,065 (from $5,183,624 to $2,859,559).
* Additional paid-in capital was adjusted by $(3,147,609) in the balance sheet; accumulated deficit changed by $(196,454) in the restatement schedule.

Positives (income statement & balance sheet)

* Operating income is positive: $404,253 for Q1 2025 (company shows an operating recovery vs prior period).
* Gross profit expanded year-over-year (Q1 2025: $2,859,559 vs Q1 2024: $2,342,101) despite slightly lower total revenue.
* Cash position and working capital improved: cash $26.997M and working capital surplus $10.083M - provides runway for integration and product development.
* Technology revenue showed strong growth vs prior year (Technology & Software $813,747 vs $255,944).
* Brokerage gross margin per MD&A: 56.36% (Q1 2025) - healthy margin on core trading business when isolated.

Negatives / risks (income statement and corporate health)

* Net income collapsed relative to prior period: $104,548 vs $833,445 - largely because "Other income (expense)" swung from +$877,691 to $(299,705). The volatility in other income (including FX remeasurement and trading positions) is material to bottom‑line results.
* The restatement is material: prior reporting overstated revenue, gross profit and APIC. Restatements undermine confidence in consolidation and period-close controls.
* Disclosure/internal control weaknesses: management concluded disclosure controls were not effective and identified a material weakness (inadequate segregation of duties, insufficient written policies).
* Auditor instability: multiple auditor changes and a recent dismissal (Olayinka) and new engagement (LAO) increase audit risk and create investor uncertainty.
* High customer funds liability ($24.53M) - large custodial balances that represent a liquidity obligation and operational risk if funds need segregation or repatriation.
* Concentration and related‑party transactions: sizable related‑party equity and financing activity (multiple issuances, Series A/B holdings concentrated with related parties, large injections from a director/related party); this raises governance and independence concerns.
* Legal/contingent items: legal correspondence received Dec 23, 2023 (APSI/Alchemy group matter) - outcome and potential impact uncertain.
* Net cash from operations is small: net cash provided by operating activities was $179,534 (Q1 2025) - modest relative to scale and potential acquisition/investment plans.

What to watch next

* Auditor report and any further audit adjustments after the restatement; independent auditor's going-concern language if repeated.
* Progress on remediation of internal control weaknesses and whether future filings show clean consolidation controls.
* Composition and use of customer funds, repatriation constraints (majority of cash held offshore), and any regulatory inquiries connected to AML/APL/ADS operations.
* Traction for Condor platform licensing (management cites 7 licensing agreements as of Q1 2025) and commercialization timeline for the Condor Investing & Trading App (target: end of 2025).
* Any material legal developments related to the Dec 2023 correspondence and acquisition‑related disputes.

Bottom line: FDCTech shows operational progress - positive operating income and stronger tech revenue - and holds a meaningful cash balance. But the restatement, control weaknesses, auditor churn, related‑party concentration and opaque "other income" swings create execution and governance risk. Investors should monitor remediation steps, subsequent audit opinions, and the company's handling of customer funds and related‑party transactions.